Viewing Study NCT00228358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-02-21 @ 4:08 AM
Study NCT ID: NCT00228358
Status: COMPLETED
Last Update Posted: 2014-11-11
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
Sponsor: University of Washington
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None Recurrent Breast Cancer View
None Recurrent Non-small Cell Lung Cancer View
None Recurrent Ovarian Epithelial Cancer View
None Recurrent Ovarian Germ Cell Tumor View
None Stage IV Breast Cancer View
None Stage IV Non-small Cell Lung Cancer View
None Stage IV Ovarian Epithelial Cancer View
None Stage IV Ovarian Germ Cell Tumor View
Keywords: